Sight Sciences (SGHT) news
Recent news
Zimmer, Sight Sciences, Edwards get upside catalyst watch: Citi
Citi analysts have highlighted Zimmer Biomet, Sight Sciences, and Edwards Lifesciences as companies poised for potential upside catalysts in the near term, according to recent market commentary. The firm’s assessment is based on anticipated developments in regulatory approvals, product launches,…
AInvest Wire · Oct 5, 2026Sight Sciences outlook FY revenue $88 million to $92 million
AInvest Wire · Aug 5, 2026Sight Sciences Q2 EPS USD -0.08
AInvest Wire · Aug 5, 2026Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Sight Sciences to Report First Quarter Financial Results on May 2, 2024 Sight Sciences, a pioneering eyecare technology firm, is set to release its first quarter financial results on May 2, 2024 [1]. As the company continues to innovate and transform care in the ophthalmic sector, investors and…
AInvest Wire · Apr 18, 2024Sight Sciences’ stock tumbled 32% premarket after revenue warning.
AInvest Wire · Sep 12, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
